Immunohistochemical studies of the expression of matrix metalloproteinase-2 and metalloproteinase-9 in human prostate cancer

Abstract

To study the expression of matrix metalloproteinase-2 and-9 in human prostate cancer, matrix metalloproteinase-2 and-9 were immunohistochemically detected in tissues of prostate cancer and benign prostatic hyperplasia (BPH). Our results showed that matrix metalloproteinase-2 and-9 levels in prostate cancer were much higher than those in tissues of BPH, with the cancer invasion being positively correlated with the expression of the metalloproteinases. It is concluded that matrix metalloproteinase-2 and-9 are better molecular markers, which are of help in the diagnosis and prediction of prognosis of prostate cancer.

Keywords

prostate cancer / matrix metalloproteinase-2 / matrix metalloproteinase-9 / immunohistochemistry

References

[1] UmbasR, SchalkenJ A, AaldersT W, et al.. Expression of the cellular adhesion molecule E-Cadherin is reduced or absent in high-grade prostate cancer. Cancer Res, 1992, 52: 5104-5104

[2] PowellW C, KnoxJ D, NavreM, et al.. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential insevere combined immunodeficient mice. Cancer Res, 1993, 53: 417-417

[3] StearnsM, StearnsM E. Evidence for increased activated metalloproteinase-2(MMP-2a) expression associated with human prostate cancer progression. Oncol Res, 1996, 8: 69-69

[4] XuanJ W, WilsonS M, ChinJ L, et al.. Metastatic NIH 3T3×LTA cell hybrids express 72KD type IV collagenase. Anticancer Res, 1995, 15: 1227-1227

[5] ZuckerS, LysikR M, ZarrabiM H, et al.. Mr 92000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res, 1993, 53: 140-140

[6] TokurakuM, SatoH, MurakamiS, et al.. Activation of the precursor of gelatinase A/72kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase and with lymph node metastasis. Int J Cancer, 1995, 64: 355-355

[7] ParsonsS L, WatsonS A, BrownP D, et al.. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin Exp Metastatis, 1997, 15: 246-246